John Harlow Named Chief Commercial Officer for Melinta Therapeutics
Melinta Therapeutics has hired pharmaceutical industry veteran John Harlow as Chief Commercial Officer. He was most recently with Baudax Bio as Chief Commercial Officer, leading marketing, sales, market access and operations. Prior to that, he served Recro Pharma as Executive Vice President, Commercial after being promoted from Vice President of Marketing. He has also held executive-level commercial roles with such notable companies as Endo Pharmaceuticals, Pfizer and Novartis.
Melinta Therapeutics is a biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings. The company is headquartered in New Haven, CT.